(Q46364456)

21 December 2017

title

Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings (English)

1 reference

21 December 2017

0 references

1 reference

1 reference

4

M F Green

1 reference

21 December 2017

author name string

K S Kee

series ordinal

1

1 reference

21 December 2017

R S Kern

series ordinal

2

1 reference

21 December 2017

B D Marshall

series ordinal

3

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

21 December 2017

published in

Schizophrenia Research

1 reference

21 December 2017

volume

31

1 reference

21 December 2017

page(s)

159-165

1 reference

21 December 2017

issue

2-3

1 reference

21 December 2017

Cue availability and affect perception in schizophrenia.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Effects of atypical antipsychotic agents on social behavior in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Responses of schizophrenics to expressions of the fundamental emotions.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Facial expression and emotional face recognition in schizophrenia and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Social functioning of schizophrenic patients: clinical and research issues

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

The Effects of Neuroleptic Drugs on the Social Interactions of Hospitalized Psychotic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Emotional processing in schizophrenia: neurobehavioral probes in relation to psychopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

The effect of risperidone on cognition in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Recognition and identification of facial stimuli by schizophrenics and patients with affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Community and interpersonal functioning in the course of schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Expressed emotion, social skill, and response to negative affect in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

Emotion recognition and social competence in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

More evidence for generalized poor performance in facial emotion perception in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900026-7

7 January 2021

10.1016/S0920-9964(98)00026-7

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

9689720

1 reference

21 December 2017